Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heritas Capital is a Singapore-based private equity and venture capital firm specializing in healthcare, education, and technology investments across the Asia-Pacific region. The firm manages a diverse range of funds, including the Heritas Venture Fund and the Asia Impact First Fund, with a strong focus on impact-driven investing. In the life sciences sector, Heritas targets innovative biotechnology, medical technology, and digital health companies that address significant unmet medical needs. They provide strategic capital and support to startups ranging from early-stage seed rounds to growth-phase expansions. Notable portfolio companies include Hummingbird Bioscience, Alentis Therapeutics, and Holmusk.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heritas Capital Management.